Wordt geladen...
Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate
Canonical mutations in IDH1 and IDH2 produce high levels of the R-enantiomer of 2-hydroxyglutarate (R-2HG), which is a competitive inhibitor of αKG-dependent enzymes and a putative oncometabolite. Mutant IDH1 collaborates with HoxA9 to induce monocytic leukemia in vivo. We employed two mouse models...
Bewaard in:
| Gepubliceerd in: | Leukemia |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5298178/ https://ncbi.nlm.nih.gov/pubmed/27063596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2016.71 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|